Total Payments
$1,151
2022 Payments
$34.12
Companies
17
Transactions
26
Medicare Patients
2,666
Medicare Billing
$189,190
Payment Breakdown by Category
Food & Beverage$1,151 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,151 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $425.98 | 7 | $0 (2021) |
| La Jolla Pharmaceutical Company | $125.00 | 1 | $0 (2018) |
| Theravance Biopharma Inc. | $122.65 | 1 | $0 (2017) |
| Grifols USA, LLC | $64.78 | 2 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $62.16 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $60.57 | 1 | $0 (2017) |
| Stryker Corporation | $53.92 | 2 | $0 (2017) |
| Insmed, Inc. | $47.97 | 1 | $0 (2019) |
| EKOS Corporation | $43.50 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $27.58 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $34.12 | 2 | Vapotherm Inc ($21.54) |
| 2021 | $18.14 | 1 | AstraZeneca Pharmaceuticals LP ($18.14) |
| 2019 | $315.20 | 5 | AstraZeneca Pharmaceuticals LP ($267.23) |
| 2018 | $345.80 | 6 | AstraZeneca Pharmaceuticals LP ($140.61) |
| 2017 | $438.18 | 12 | Theravance Biopharma Inc. ($122.65) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: COVID-19 | ||||||
| 08/19/2022 | Vapotherm Inc | — | Food and Beverage | In-kind items and services | $21.54 | General |
| 02/18/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Respiratory | ||||||
| 12/20/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Respiratory | ||||||
| 12/12/2019 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $47.97 | General |
| 10/01/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $67.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $104.28 | General |
| Category: Respiratory | ||||||
| 03/14/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $76.55 | General |
| 10/25/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GIAPREZA | ||||||
| 08/23/2018 | EKOS Corporation | EKOSONIC (Device) | Food and Beverage | In-kind items and services | $43.50 | General |
| Category: PERIPHERAL VASCULAR | ||||||
| 05/24/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 02/26/2018 | Cook Medical LLC | COOK MEDICAL CENTESIS & DRAINAGE (Device) | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| Category: Critical Care | ||||||
| 01/17/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $109.95 | General |
| Category: Respiratory | ||||||
| 11/21/2017 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2017 | Stryker Corporation | Altrix (Device) | Food and Beverage | Cash or cash equivalent | $34.66 | General |
| Category: Patient Handling - PH | ||||||
| 08/09/2017 | Stryker Corporation | Transport Stretcher (Device) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: EMS | ||||||
| 06/28/2017 | SANOFI-AVENTIS U.S. LLC | DIABETES - DISEASE (Drug) | Food and Beverage | In-kind items and services | $60.57 | General |
| 06/16/2017 | Astute Medical, Inc. | NephroCheck Test (Device) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Nephrology | ||||||
| 05/10/2017 | Theravance Biopharma Inc. | — | Food and Beverage | In-kind items and services | $122.65 | General |
| 04/05/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $47.61 | General |
| Category: Pulmonology | ||||||
| 03/22/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Cardiovascular | ||||||
| 03/08/2017 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2017 | BOSTON SCIENTIFIC CORPORATION | ALAIR BRONCHIAL THERMOPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $62.16 | General |
| Category: BRONCHIAL THERMOPLASTY | ||||||
| 01/26/2017 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 598 | 715 | $107,823 | $29,758 |
| 2022 | 10 | 701 | 862 | $128,838 | $34,807 |
| 2021 | 11 | 586 | 812 | $187,794 | $52,721 |
| 2020 | 14 | 781 | 1,089 | $251,465 | $71,904 |
Total Patients
2,666
Total Services
3,478
Medicare Billing
$189,190
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 96 | $54,528 | $15,202 | 27.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 72 | $15,192 | $4,238 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 31 | $9,777 | $2,746 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $9,646 | $2,511 | 26.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 19 | 22 | $6,292 | $1,747 | 27.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 137 | 138 | $4,195 | $1,182 | 28.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 152 | 154 | $3,457 | $965.06 | 27.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 79 | 80 | $2,568 | $580.64 | 22.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 76 | 77 | $1,590 | $443.84 | 27.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 19 | 19 | $577.60 | $143.20 | 24.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 121 | $68,970 | $18,678 | 27.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 93 | $17,298 | $4,968 | 28.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 29 | $12,341 | $2,855 | 23.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 32 | $8,544 | $2,384 | 27.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 22 | 24 | $6,888 | $1,866 | 27.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 186 | 188 | $4,221 | $1,207 | 28.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 129 | 131 | $3,982 | $1,145 | 28.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 89 | 89 | $2,857 | $649.79 | 22.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 98 | 100 | $2,065 | $595.44 | 28.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 55 | 55 | $1,672 | $458.55 | 27.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 59 | 202 | $114,860 | $32,746 | 28.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 94 | $17,430 | $5,111 | 29.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 44 | $18,969 | $4,401 | 23.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 45 | $11,985 | $3,518 | 29.4% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 29 | 34 | $9,728 | $2,843 | 29.2% |
About Dr. Allen Smith, MD
Dr. Allen Smith, MD is a Pulmonary Disease healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851398259.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allen Smith, MD has received a total of $1,151 in payments from pharmaceutical and medical device companies, with $34.12 received in 2022. These payments were reported across 26 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,151).
As a Medicare-enrolled provider, Smith has provided services to 2,666 Medicare beneficiaries, totaling 3,478 services with total Medicare billing of $189,190. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Knoxville, TN
- Active Since 06/30/2005
- Last Updated 02/19/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1851398259
Products in Payments
- FASENRA (Drug) $232.74
- GIAPREZA (Drug) $125.00
- LOKELMA (Drug) $67.89
- Prolastin-C (Biological) $64.78
- ALAIR BRONCHIAL THERMOPLASTY SYSTEM (Device) $62.16
- DIABETES - DISEASE (Drug) $60.57
- EKOSONIC (Device) $43.50
- Altrix (Device) $34.66
- BRILINTA (Drug) $30.66
- XOLAIR (Biological) $27.58
- NephroCheck Test (Device) $20.27
- Esbriet (Biological) $19.50
- Transport Stretcher (Device) $19.26
- FASENRA (Biological) $18.14
- COOK MEDICAL CENTESIS & DRAINAGE (Device) $17.19
- ELIQUIS (Drug) $14.18
- Veklury (Drug) $12.58
- TRELEGY ELLIPTA (Drug) $12.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Knoxville
Prof. Rajiv Dhand, Md, MD
Pulmonary Disease — Payments: $255,078
Pulmonary Disease $255,078
Dr. Varun Shah
Pulmonary Disease — Payments: $39,294
Pulmonary Disease $39,294
J. Turner, Md, MD
Pulmonary Disease — Payments: $15,733
Pulmonary Disease $15,733
Jared Kravitz, Md, MD
Pulmonary Disease — Payments: $8,913
Pulmonary Disease $8,913
Paul Branca, Md, MD
Pulmonary Disease — Payments: $8,504
Pulmonary Disease $8,504
Elise Schriver, M.d, M.D
Pulmonary Disease — Payments: $8,131
Pulmonary Disease $8,131